ストックスクリーナーアプリを入手
236.27
1.37%
-3.83
Resmed Inc (RMD) 最新ニュース
XY Capital Ltd Buys Shares of 36,769 ResMed Inc. $RMD - MarketBeat
Paralel Advisors LLC Buys Shares of 10,293 ResMed Inc. $RMD - MarketBeat
SGL Investment Advisors Inc. Purchases New Position in ResMed Inc. $RMD - MarketBeat
Wealthfront Advisers LLC Makes New Investment in ResMed Inc. $RMD - MarketBeat
13,498 Shares in ResMed Inc. $RMD Purchased by Fairtree Asset Management Pty Ltd - MarketBeat
Danske Bank A S Makes New Investment in ResMed Inc. $RMD - MarketBeat
Bank of New York Mellon Corp Takes $818.03 Million Position in ResMed Inc. $RMD - MarketBeat
Baird Mid Cap Growth Fund's ResMed Inc(RMD) Holding History - GuruFocus
ResMed Stock Bounces Back 4% This Week After Erasing Its Post Earnings Selloff - TIKR.com
ResMed (RMD) Today: Moves 0.67% Down to $228.44 in the Latest Session; Range Check: Price Remains Between $217.02 Support and $239.86 Resistance in the Current UpdateInvestment Factor - Vinanet
ResMed (RMD) Levels: Slides 0.10% to $229.76 on the Day; Current Setup: Traders Can Monitor the $218.27-$241.25 Range on the DayIV Spike - Vinanet
ResMed (NYSE:RMD) Faces Fresh Market Attention - Kalkine Media
ResMed stock climbs after earnings beat as analysts see valuation full - Ad-hoc-news.de
ResMed (NYSE:RMD) Upgraded to Hold at Rothschild & Co Redburn - MarketBeat
Rothschild & Co Redburn Initiates ResMed(RMD.US) With Hold Rating, Announces Target Price $230 - Moomoo
350,860 Shares in ResMed Inc. $RMD Acquired by Mitsubishi UFJ Asset Management Co. Ltd. - MarketBeat
BlackRock Inc. Makes New $2.40 Billion Investment in ResMed Inc. $RMD - MarketBeat
ResMed (RMD): Finishes 4.85% Up at $230.65 in the Current Update; Price Levels: Traders Can Monitor the $219.12-$242.18 Range at the CloseBreadth Thrust - Vinanet
Is It Too Late to Buy ResMed Inc (RMD) After 4.8% Rally? GF Value Says Undervalued - GuruFocus
ResMed Inc. stock rises Wednesday, outperforms market - MarketWatch
Resmed Inc Stock (RMD) Moved Up by 3.43% on Aug 19: What Investors Need To Know - TradingKey
ResMed, Inc.: Target Price Consensus and Analysts Recommendations | RME | US7611521078 - marketscreener.com
Oxbow Advisors LLC Invests $5.57 Million in ResMed Inc. $RMD - MarketBeat
Rothschild Redburn initiates ResMed stock coverage with neutral rating By Investing.com - Investing.com South Africa
Rothschild Redburn initiates ResMed stock coverage with neutral rating - Investing.com
Deutsche Bank AG Takes Position in ResMed Inc. $RMD - MarketBeat
Resmed Announces Board Leadership Transition and Director Retirement - The Globe and Mail
ResMed stock slips as Q4 revenue rose 9% - AD HOC NEWS
Resmed board set to get new lead director - HME News
RESMED INC CDI COM USD0.004 (10CDI/1SHS) To Go Ex-Dividend On August 19th, 2026 With 0.066 USD Dividend Per Share - Moomoo
UNIVEST FINANCIAL Corp Acquires Shares of 12,846 ResMed Inc. $RMD - MarketBeat
Perigon Wealth Management LLC Invests $4.60 Million in ResMed Inc. $RMD - MarketBeat
5,358 Shares in ResMed Inc. $RMD Purchased by Flputnam Investment Management Co. - MarketBeat
Resmed Announces Appointment of Carol Burt as Lead Director and Planned Retirement of Director Ron Taylor - Koreabizwire
ResMed (ASX:RMD) Faces Market Attention as Healthcare Technology Portfolio Continues to Evolve - Kalkine
ResMed (RMD) Announces Auditor Transition to PwC and Board Leade - GuruFocus
ResMed Replaces KPMG with PwC and Names Carol Burt as Lead Director - Kalkine
ResMed names Carol Burt as lead director, Ron Taylor to retire - Investing.com
ResMed Inc. stock falls Monday, underperforms market - MarketWatch
Resmed Names Carol Burt Lead Director as Ron Taylor Retires After 21 Years on Board - Quiver Quantitative
A lead director's 21-year Resmed tenure is set to end in November - Stock Titan
ResMed’s (RMD) Sleep Business Booms Even As One Product Stumbles - Yahoo Finance
ResMed Inc. (RMD) Stock Analysis: Assessing a 10% Potential Upside in Healthcare Innovation - DirectorsTalk Interviews
ResMed names Carol Burt lead director as Ron Taylor steps down - Bitget
Could Cochlear (ASX:COH) and ResMed (ASX:RMD) Shape the Next Chapter? - Kalkine Media
87,722 Shares in ResMed Inc. $RMD Purchased by Avalon Trust Co - MarketBeat
41,381 Shares in ResMed Inc. $RMD Acquired by ABN AMRO Bank N.V. - MarketBeat
Why You Should Consider Buying ResMed Stock After Its First-Ever Annual Guide - TIKR.com
The 5 Most Interesting Analyst Questions From ResMed’s Q2 Earnings Call - Yahoo Finance
ResMed Inc. stock falls Friday, underperforms market - MarketWatch
ResMed Inc.: Financial Data Forecasts Estimates and Expectations | RMEA | AU000000RMD6 - marketscreener.com
ResMed, Inc.: Financial Data Forecasts Estimates and Expectations | RME | US7611521078 - marketscreener.com
ResMed (ASX:RMD) Keeps Dividend Momentum Going: Keep It on Your Radar - Kalkine
ResMed to sell MatrixCare business for $490 million - Minichart
ResMed Inc. Submits Annual 10-K Report for Fiscal Year Ending June 30, 2026 - Kalkine Media
ResMed Inc. Files Annual Form 10-K Report for Fiscal Year Ended June 30, 2026 - Kalkine
ResMed Submits 2026 Fiscal Year-End 10-K Annual Report Detailing Financial and Operational Metrics - Kalkine Media
RESMED INC. : RBC RAISES TARGET PRICE TO $244 FROM $234 - webull.com
RESMED INC FY 2026: Revenue $5.65B, EPS $10.43— 10-K Summary - TradingView
How Investors May Respond To ResMed (RMD) Dividend Hike And Ventilator Recall Headwinds - simplywall.st
Handelsbanken Fonder AB Raises Stock Position in ResMed Inc. $RMD - MarketBeat
Weekly Earnings Wrap: CBA, REA Group, Westpac, Resmed and more - Morningstar Australia
RESMED INC. : PIPER SANDLER CUTS TARGET PRICE TO $225 FROM $233 - webull.com
ResMed Inc. Stock 12‑Month Price Target Cut to $258.47, Implies 14% Upside - TradingView
ResMed Could Expand Into More Sleep Disorder Treatments -- Interview - Moomoo
ResMed Inc. (RMD) Stock Forecasts - Yahoo Finance
J.P. Morgan Sticks to Their Buy Rating for Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (RMD) - The Globe and Mail
ResMed (RMD) Stock May Be 31% Undervalued After Soft FY27 Outlook - Yahoo Finance
0.54%
2.30%
大文字化:
|
ボリューム (24 時間):